IP Library › Granted Patent US 9,676,777
Granted Patent B2
US 9,676,777 · App. 15/007,906 · Granted Jun 13, 2017

Compounds useful for producing an optically active diazabicyclooctane compound

Inventors: Takao Abe (Kanagawa, JP); Masayuki Okue (Kanagawa, JP); Yoshiaki Sakamaki (Kanagawa, JP)
Assignee: MEIJI SEIKA PHARMA CO., LTD.
C07D471/08C07D211/60C07B2200/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,676,777
App. No.
15/007,906
Granted
Jun 13, 2017
Kind
B2
Abstract

An optically active (2S,5R)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid compound defined by the following formula (F): wherein R 1 represents CO 2 R, CO 2 M, or CONH 2 , wherein R represents an allyl group or a benzyl group, and M represents a hydrogen atom, an inorganic cation, or an organic cation; and R 2 represents a benzyl group or an allyl group.

Claims (32)

1. An optically active (2S,5R)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid compound defined by the following formula (F):

wherein R 1 represents CO 2 M or CONH 2 ;

M represents an inorganic cation selected from the group consisting of sodium, potassium, lithium and calcium or an organic cation selected from the group consisting of trimethylamine, triethylamine, dicyclohexylamine, tetramethylammonium, tetraethylammonium, tetrabutylammonium and triethylbenzylammonium; and

R 2 represents a benzyl group or an allyl group.

2. A process for preparing the compound defined by the formula (F) according to claim 1 , which comprises subjecting a compound represented by formula (E) below to an intramolecular urea formation, and then subjecting the resultant compound represented by formula (F1) below to at least one of the steps (a) to (c) below:

wherein Bn represents a benzyl group, and tBu represents a tert-butyl group;

wherein Bn represents a benzyl group, and tBu represents a tert-butyl group;

step (a) for converting the compound of the formula (F1) to a form of a salt of an inorganic cation or an organic cation,

step (b) for treating the compound of the formula (F1) with an acid to convert the compound of the formula (F1) to a free acid, and then

performing a carbamoylation for the carboxylic acid group of the free acid,

step (c) for removing the benzyl group of the benzyloxy group at the 6-position, of the formula (F1) and then

converting the group at the 6-position to an allyloxy.

3. The compound according to claim 1 , wherein the compound is (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide.

4. The compound according to claim 1 , wherein R 1 is CO 2 M, and M is the inorganic cation.

5. The compound according to claim 1 , wherein R 1 is CO 2 M, and M is the organic cation.

6. The compound according to claim 1 , wherein R 1 is CONH 2 .

7. A process for preparing the compound defined by the following formula (F)

wherein R 1 represents CO 2 R, CO 2 M, or CONH 2 ,

wherein R represents an allyl group or a benzyl group, and

M represents a hydrogen atom, an inorganic cation, or an organic cation; and

R 2 represents a benzyl group or an allyl group,

the process comprising

subjecting a compound represented by formula (E) below to an intramolecular urea formation, and then subjecting the resultant compound represented by formula (F1) below to at least one of the steps (a) to (g) below:

wherein Bn represents a benzyl group, and tBu represents a tert-butyl group;

wherein Bn represents a benzyl group, and tBu represents a tert-butyl group;

step (a) for cleaving the ester group of the formula (F1),

step (b) for converting the compound of the formula (F1) to a form of a salt of an inorganic cation or an organic cation,

step (c) for treating the compound of the formula (F1) with an acid to convert the compound of the formula (F1) to a free acid,

step (d) for performing a carbamoylation for the carboxylic acid group of the formula (F1),

step (e) for converting the carboxylic acid group of the formula (F1) to an ester,

step (f) for removing the benzyl group of the benzyloxy group at the 6-position, of the formula (F1) and

step (g) for converting the group at the 6-position to an allyloxy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2016
From: ABE, TAKAO; OKUE, MASAYUKI; SAKAMAKI, YOSHIAKI
To: MEIJI SEIKA PHARMA CO., LTD.
Reel/Frame 037599/0761 →
Continuity (5)
Continuation 14676179 · Apr 1, 2015
Division 14287380 · May 27, 2014
Division 13173002 · Jun 30, 2011
Provisional Application 61459954 · Dec 22, 2010
Related Publication 20160137645A1 · May 19, 2016